Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Clear all filters
Clear all filters
ChartWise Medical Systems, Inc.
June 2021

ChartWise Medical Systems, Inc.

Financial Advisor to ChartWise Medical Systems, Inc. on its sale to Iodine Software, a portfolio company of Silversmith Capital Partners and Bain Capital Ventures
HEALTHCARE M&A ADVISORY US
View transaction detail
Susquehanna Growth Equity
May 2021

Susquehanna Growth Equity

Financial Advisor to Susquehanna Growth Equity on its Majority Investment in MediSpend
MediSpend logo
TECHNOLOGY HEALTHCARE M&A ADVISORY FINANCIAL SPONSORS US
View transaction detail
Trulieve
US$2b
May 2021

Trulieve

Financial Advisor to Trulieve on its acquisition of Harvest Health & Recreation Inc.
CANNABIS HEALTHCARE M&A ADVISORY CANADA
Ascend Wellness Holdings
US$29m
May 2021

Ascend Wellness Holdings

Sole Lead Bookrunner (IPO)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS US
obp Medical Corporation
US$60m
May 2021

obp Medical Corporation

Financial Advisor to obp Medical Corporation on sale of assets to CooperSurgical, Inc
CooperSurgical, Inc logo
HEALTHCARE M&A ADVISORY US
View transaction detail
PeriGen
April 2021

PeriGen

Exclusive Financial Advisor to PeriGen on its acquisition by Halma (LSE: HLMA)
HEALTHCARE M&A ADVISORY US UK
Privia Health Group
US$516m
April 2021

Privia Health Group

Bookrunner (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
SeaSpine
US$101m
April 2021

SeaSpine

Joint Bookrunner (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Akoya Biosciences, Inc
US$151m
April 2021

Akoya Biosciences, Inc

Joint Bookrunner (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
BCTG Acquisition Corp.
April 2021

BCTG Acquisition Corp.

Financial Advisor to BCTG Acquisition Corp. on its merger with Tango Therapeutics
Tango Therapeutics Logo
HEALTHCARE M&A ADVISORY US
View transaction detail
Sol Cuisine
C$13m
April 2021

Sol Cuisine

Lead Bookrunner (RTO)
CONSUMER AND RETAIL HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Trulieve
C$288m
April 2021

Trulieve

Sole Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA

Here to support you...

  1. Company information as at 31 March 2021
  2. Transactions valued above C$1.5 million

* Transactions displayed here include transactions of Canaccord Genuity and its predecessors. The logos used in the tombstones represent Canaccord Genuity’s clients unless otherwise specified in the transaction description